MarketCap
Silence Therapeutics plc SLN
€ 17.73
0.51%
Facebook
X
Telegram
Land |
 Großbritannien |
IPO-Jahr |
- |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
142 M |
Marktkapitalisierung |
$ 2.8 B |
EBITDA (LTM) |
$ -49.6 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Jounce Therapeutics
JNCE
|
- | - | $ 98.4 M | Nasdaq Global Select Market |  USA |
 |
Verona Pharma plc
VRNA
|
- | - | $ 69.7 B | Nasdaq Global Select Market | Britain |
 |
Corner Growth Acquisition Corp.
COOL
|
- | -0.89 % | $ 114 M | Nasdaq Global Select Market | USA |
 |
Acorda Therapeutics
ACOR
|
- | -24.86 % | $ 820 K | Nasdaq Global Select Market | USA |
 |
CRISPR Therapeutics AG
CRSP
|
$ 49.0 | -0.79 % | $ 4.41 B | Nasdaq Global Market,SPB |  Schweiz |
 |
Corvus Pharmaceuticals
CRVS
|
$ 10.44 | -0.9 % | $ 824 M | Nasdaq Global Market | USA |
 |
UroGen Pharma Ltd.
URGN
|
$ 34.05 | -1.29 % | $ 1.64 B | Nasdaq Global Select Market |  Israel |
 |
Ampio Pharmaceuticals
AMPE
|
- | -11.43 % | $ 502 K | NYSE American | USA |
 |
United Therapeutics Corporation
UTHR
|
$ 593.02 | 0.94 % | $ 26.3 B | Nasdaq Global Select Market,SPB | USA |
 |
Vericel Corporation
VCEL
|
$ 42.99 | 1.08 % | $ 2.16 B | Nasdaq Global Select Market,SPB | USA |
 |
Veracyte
VCYT
|
$ 48.22 | 0.61 % | $ 3.79 B | Nasdaq Global Market,SPB | USA |
|
Champions Oncology
CSBR
|
$ 4.82 | 2.12 % | $ 66.7 M | Nasdaq Capital Market | USA |
 |
Mersana Therapeutics
MRSN
|
- | - | $ 3.56 B | Nasdaq Global Select Market | USA |
 |
Vir Biotechnology
VIR
|
$ 11.02 | 4.27 % | $ 1.53 B | Nasdaq Global Select Market,SPB | USA |
 |
Viking Therapeutics
VKTX
|
$ 24.23 | -0.72 % | $ 2.73 B | Nasdaq Capital Market | USA |
 |
CymaBay Therapeutics
CBAY
|
- | - | $ 3.45 B | Nasdaq Global Select Market | USA |
 |
Freeline Therapeutics Holdings plc
FRLN
|
- | - | $ 384 M | Nasdaq Global Select Market | Britain |
 |
Cabaletta Bio
CABA
|
$ 1.34 | -9.18 % | $ 135 M | Nasdaq Global Select Market | USA |
 |
CytomX Therapeutics
CTMX
|
$ 2.23 | -4.09 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Vanda Pharmaceuticals
VNDA
|
$ 3.95 | -1.62 % | $ 233 M | Nasdaq Global Select Market,SPB | USA |
 |
Allakos
ALLK
|
- | - | $ 28.6 M | Nasdaq Global Select Market,SPB | USA |
 |
Timber Pharmaceuticals
TMBR
|
- | - | $ 717 K | NYSE American | USA |
 |
Verrica Pharmaceuticals
VRCA
|
$ 3.4 | -3.68 % | $ 36.2 M | Nasdaq Global Market | USA |
 |
Viridian Therapeutics
VRDN
|
$ 23.31 | 4.2 % | $ 2.37 B | Nasdaq Capital Market | USA |
 |
G1 Therapeutics
GTHX
|
- | - | $ 370 M | Nasdaq Global Select Market,SPB | USA |
 |
Verastem
VSTM
|
$ 9.9 | -1.34 % | $ 686 M | Nasdaq Global Market | USA |
 |
VistaGen Therapeutics
VTGN
|
$ 0.17 | -3.9 % | $ 6.47 M | Nasdaq Global Select Market | USA |
 |
Voyager Therapeutics
VYGR
|
$ 1.76 | 0.86 % | $ 103 M | Nasdaq Global Select Market | USA |
|
Amryt Pharma plc
AMYT
|
- | - | $ 621 M | Nasdaq Global Select Market | Britain |
 |
Kinnate Biopharma
KNTE
|
- | - | $ 123 M | Nasdaq Global Select Market | USA |
|
Cerevel Therapeutics Holdings
CERE
|
- | - | $ 7.29 B | Nasdaq Capital Market | USA |
 |
NexImmune
NEXI
|
- | 70.13 % | $ 4.12 M | Nasdaq Global Market | USA |
 |
Wave Life Sciences Ltd.
WVE
|
$ 3.23 | -0.16 % | $ 545 M | Nasdaq Global Select Market |  Singapore |
 |
Theravance Biopharma
TBPH
|
$ 17.03 | 0.03 % | $ 857 M | Nasdaq Global Select Market |  Cayman-islands |
 |
Xenetic Biosciences
XBIO
|
$ 1.72 | 3.78 % | $ 2.93 M | Nasdaq Capital Market | USA |
|
XBiotech
XBIT
|
$ 1.82 | -5.7 % | $ 55.5 M | Nasdaq Global Select Market | USA |
 |
Xenon Pharmaceuticals
XENE
|
$ 35.76 | 1.19 % | $ 2.83 B | Nasdaq Global Select Market |  Canada |
 |
Xeris Pharmaceuticals
XERS
|
$ 10.21 | 0.05 % | $ 1.64 B | Nasdaq Global Select Market | USA |
 |
X4 Pharmaceuticals
XFOR
|
$ 3.26 | 0.46 % | $ 138 M | Nasdaq Capital Market | USA |
 |
IMV
IMV
|
- | - | $ 13.1 M | Nasdaq Global Select Market | Canada |
 |
22nd Century Group
XXII
|
$ 0.09 | -54.43 % | $ 16.6 K | NYSE American | USA |
 |
Karuna Therapeutics
KRTX
|
- | - | $ 12.2 B | Nasdaq Global Market,SPB | USA |
 |
Chimerix
CMRX
|
- | - | $ 756 M | Nasdaq Global Select Market | USA |
 |
Atreca
BCEL
|
- | -11.76 % | $ 5.79 M | Nasdaq Global Select Market | USA |
 |
LogicBio Therapeutics
LOGC
|
- | - | $ 229 M | Nasdaq Global Market | USA |
 |
Zai Lab Limited
ZLAB
|
$ 24.36 | 1.35 % | $ 26.7 B | Nasdaq Global Select Market |  China |
|
89bio
ETNB
|
- | - | $ 1.55 B | Nasdaq Global Market | USA |
 |
Zentalis Pharmaceuticals
ZNTL
|
$ 2.06 | -6.79 % | $ 148 M | Nasdaq Global Market | USA |
 |
Zymeworks
ZYME
|
$ 28.38 | 0.57 % | $ 1.46 B | NYSE | Canada |
 |
Fusion Pharmaceuticals
FUSN
|
- | - | $ 1.41 B | Nasdaq Global Select Market | Canada |